Across TCGA pan-cancer cohorts, LINC01494 RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated LINC01494 data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher LINC01494 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC01494 expression acts as an unfavorable survival marker, although some lineages such as UCS and LGG show a favorable association.

COAD, UCS, and THYM are the cancer types where LINC01494 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	DFS	Median	II,III,IV	0.557	0.722	<.001	97	view →
UCS	DFS	Median	II,III,IV	0.581	0.139	<.001	92	view →
THYM	DFS	Quartile	III,IV	0.179	1.000	.002	57	view →
ACC	DFS	Tertile	All	0.122	0.600	.001	54	view →
UCEC	DFS	Tertile	All	0.761	0.870	<.001	50	view →
KICH	OS	Tertile	All	0.082	0.877	<.001	36	view →
LGG	DFS	Tertile	All	0.832	0.682	<.001	31	view →
LUSC	DFS	Quartile	III,IV	0.158	0.788	.002	29	view →
KIRC	OS	Quartile	All	0.532	0.672	.003	22	view →
LAML	DFS	Tertile	All	0.373	0.667	.005	20	view →
GBM	DFS	Tertile	All	0.185	0.345	.008	18	view →
CHOL	OS	Tertile	III,IV	0.275	0.886	.045	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 25 lineages.

Exploration

Same gene, other analysis: LINC01494 tumor-vs-normal RNA expression · all LINC01494 data types